The largest database of trusted experimental protocols

Qiasymphony robot

Manufactured by Qiagen
Sourced in Germany

The QIAsymphony robot is an automated sample processing platform designed for high-throughput nucleic acid extraction and purification. It is capable of handling a wide range of sample types and can be used in a variety of applications, such as clinical diagnostics, research, and forensics.

Automatically generated - may contain errors

28 protocols using qiasymphony robot

1

Measuring Specimen Cellularity with GUSB

Check if the same lab product or an alternative is used in the 5 most similar protocols
We amplified the β-glucuronidase (GUSB) housekeeping gene to assess specimen cellularity in selected specimens, following a previously published protocol [18 (link)]. In brief, RNA was extracted from the NP using the DSP virus Pathogen Minikit on the QiaSymphony Robot instruments (Qiagen, Valencia, CA), reverse-transcribed to complementary DNA, and subsequently amplified by using the HEQC one-step kit (Seqplexing, Valencia, Spain) in the LightCycler 480 Real-Time PCR System Version II (Roche Diagnostics, Pleasanton).
+ Open protocol
+ Expand
2

Circulating DNA Purification from Plasma

Check if the same lab product or an alternative is used in the 5 most similar protocols
DNA was purified from 4 mL plasma after thawing and centrifugation for 10 min at 10,000 g using QIAsymphony Circulating DNA kit (Qiagen, Venlo, The Netherlands). An internal control, 20 µL CPP1, was added [25 (link)] and the DNA was eluted in 60 µL before the addition of 340 µL water. The QIAsymphony robot (Qiagen) was used for purification.
+ Open protocol
+ Expand
3

MyCode® Participant Enrollment and Sample Collection

Check if the same lab product or an alternative is used in the 5 most similar protocols
When a participant enrolls in MyCode® this information is entered into their GHS EHR. This creates an automatic order for the collection of MyCode® samples that is activated when the participant has blood drawn for clinical testing in a GHS outpatient lab. The MyCode® blood order is triggered in response to future outpatient blood draws (maximum 12 times per year), resulting in serial sample collection. MyCode samples are transported to a central processing lab in the Geisinger Department of Laboratory Medicine and then to the genomics core laboratory for final processing. For the initial MyCode blood draw 4 ml of EDTA-whole blood and two 4 ml serum-separator tube samples are obtained. For subsequent blood draws only serum is collected. One ml aliquots of whole blood are used for DNA extraction on a Qiagen QiaSymphony robot. DNA is eluted into 2-dimensional barcoded tubes; purity and yield of DNA are determined by ultraviolet spectroscopy. Samples are given a unique study identification number. A secure key linking the sample identification number to a specific patient is maintained by the MyCode® team. Additional details are provided in the online Supplementary Information.
+ Open protocol
+ Expand
4

DNA and RNA Extraction from Blood and Tissue

Check if the same lab product or an alternative is used in the 5 most similar protocols
Blood DNA was extracted using either the QIASymphony robot (Qiagen) together with the QIASymphony DNA Midi kit (Qiagen) or manually by NucleoSpin Blood, Mini DNA extraction kit (Macherey–Nagel). Tissue DNA was extracted using the AllPrep DNA/RNA/miRNA extraction kit (Qiagen). Tissue pieces stored in RNAlater were homogenized in RLT buffer using the BeadBeater (Biospec) with zirconia beads and after cell lysis the RNA and DNA containing fractions were separated. Concentration and purity were measured using Qubit Fluorometric Quantification (ThermoFisher).
+ Open protocol
+ Expand
5

Plasma cfDNA Purification Protocol

Check if the same lab product or an alternative is used in the 5 most similar protocols
cfDNA was purified from 4 mL of plasma using a QIAsymphony robot (Qiagen, Hilden, Germany), using a DSP Virus/Pathogen Midi-kit (ref. No. 937,055) as previously described [13 (link)]. The purified cfDNA was eluted into 60 μL of AVE buffer.
+ Open protocol
+ Expand
6

DNA Extraction from Blood, Tissue, and Buccal Swabs

Check if the same lab product or an alternative is used in the 5 most similar protocols
DNA was extracted from EDTA blood using either manual salt extraction or the QIASymphony DNA Midi kit (Qiagen, Venlo, Netherlands) on the QIASymphony robot (Qiagen). DNA was extracted from muscle tissue using the DNeasy blood and tissue kit (Qiagen). Buccal swab samples were stored on FTA cards from which DNA subsequently was eluted using a boiling method as follows: first, 2–3 punches of each FTA card were placed in a tube and washed three times in 180 μl ddH2O; second, elution was done by adding 25 μl ddH2O to each sample and boiling this for 30 min at 95 °C.
+ Open protocol
+ Expand
7

Extracellular DNA Extraction from Fluid Samples

Check if the same lab product or an alternative is used in the 5 most similar protocols
Fluid samples (3–500 mL) were collected in sterile containers and plasma samples (10 mL) in Vacutainer tubes (BD, Plymouth, UK). After a first centrifugation step (509 g, 10 min), the supernatants were transferred to a new tube and immediately submitted to a second centrifugation followed by cfDNA purification. The sediments of the first and second centrifugation, if present, were extended on slides, stained by hematoxylin and examined under a microscope. Purification of cfDNA from supernatants (1.2 mL) was performed with the QIAsymphony® DSP Virus/Pathogen Midi Kit using a QIAsymphony robot (Qiagen), following the manufacturer’s instructions. Extraction was performed in duplicates; cfDNA was purified from two aliquots of fluid. The final elution volume was 30 µL per aliquot.
+ Open protocol
+ Expand
8

MyCode® Participant Enrollment and Sample Collection

Check if the same lab product or an alternative is used in the 5 most similar protocols
When a participant enrolls in MyCode® this information is entered into their GHS EHR. This creates an automatic order for the collection of MyCode® samples that is activated when the participant has blood drawn for clinical testing in a GHS outpatient lab. The MyCode® blood order is triggered in response to future outpatient blood draws (maximum 12 times per year), resulting in serial sample collection. MyCode samples are transported to a central processing lab in the Geisinger Department of Laboratory Medicine and then to the genomics core laboratory for final processing. For the initial MyCode blood draw 4 ml of EDTA-whole blood and two 4 ml serum-separator tube samples are obtained. For subsequent blood draws only serum is collected. One ml aliquots of whole blood are used for DNA extraction on a Qiagen QiaSymphony robot. DNA is eluted into 2-dimensional barcoded tubes; purity and yield of DNA are determined by ultraviolet spectroscopy. Samples are given a unique study identification number. A secure key linking the sample identification number to a specific patient is maintained by the MyCode® team. Additional details are provided in the online Supplementary Information.
+ Open protocol
+ Expand
9

Plasma DNA Extraction on QIAsymphony

Check if the same lab product or an alternative is used in the 5 most similar protocols
DNA was purified from 1 ml of plasma using a QIAsymphony virus/bacteria midi-kit on a QIAsymphony robot (Qiagen), according to the manufacturer’s instructions. DNA was eluted in 110 ul. AVE buffer which was supplied with the kit.
+ Open protocol
+ Expand
10

Circulating Free DNA Extraction

Check if the same lab product or an alternative is used in the 5 most similar protocols
DNA from the two cell lines was isolated using the QIAamp Mini Kit (Qiagen, Hilden, Germany) according to the manufacturer's instructions. Circulating-free DNA was purified as follows: 15 ml blood was withdrawn from patients and collected in Vacutainer tubes (BD, Plymouth, UK). Plasma and serum were isolated by centrifugation twice at 2300 r.p.m. for 10 min. The supernatant (serum or plasma) was aliquoted and used immediately for cfDNA isolation or stored at −80 °C. Cell-free DNA was purified from serum and plasma for each patient (1.2 ml). In the rare instances that the volume of the serum and plasma sample obtained from a patient was between 1 and 1.2 ml, PBS up to 1.2 ml was added to the samples, which were then purified using the QIAsymphony robot (Qiagen) and the QIAsymphony DSPVirus/Pathogen Midi Kit, according to the manufacturer's instructions, and cfDNA was eluted in a final volume of 30 μl. Since correct preanalytical handling of blood specimens is crucial to maintain the sample informative, the process was standardised (in terms of blood collection, sample centrifugation and cfDNA extraction) in the Department of Public Health of the University of Naples Federico II, and all procedures were performed in-house by a nurse belonging to the laboratory staff.
+ Open protocol
+ Expand

About PubCompare

Our mission is to provide scientists with the largest repository of trustworthy protocols and intelligent analytical tools, thereby offering them extensive information to design robust protocols aimed at minimizing the risk of failures.

We believe that the most crucial aspect is to grant scientists access to a wide range of reliable sources and new useful tools that surpass human capabilities.

However, we trust in allowing scientists to determine how to construct their own protocols based on this information, as they are the experts in their field.

Ready to get started?

Sign up for free.
Registration takes 20 seconds.
Available from any computer
No download required

Sign up now

Revolutionizing how scientists
search and build protocols!